(Q37710295)

English

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.

scientific article published on June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

chemoradiotherapy

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Aaron T Wild

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Xiaobu Ye

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Susannah G Ellsworth

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jessica A Smith

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Amol K Narang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tanu Garg

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jian Campian

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Daniel A Laheru

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Lei Zheng

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christopher L Wolfgang

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stuart A Grossman

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Joseph M Herman

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 June 2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

American Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

38

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

259-265

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Modelling prognostic factors in advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

The immune system--is it relevant to cancer development, progression and treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Immune surveillance of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 August 2017

Clinical trials of vaccines for immunotherapy in pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

6 September 2017

Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

14 September 2017

Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

14 September 2017

Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 June 2018

The mechanism of lymphopenia produced by chronic irradiation of the rat spleen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 June 2018

The radiosensitivity of human haemopoietic progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

23 June 2018

Prognostic factors after resection of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

1 September 2018

Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

1 September 2018

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

1 September 2018

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

1 September 2018

The response of the granulocytic progenitor cells (CFU-C) of blood and bone marrow in dogs exposed to low doses of X irradiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3991773

1 September 2018

Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro studies on the sensitivity of canine granulopoietic progenitor cells (GM-CFC) to ionizing radiation: differences between steady state GM-CFC from blood and bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosome aberrations in the peripheral lymphocytes induced by brachytherapy and external cobalt teletherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of dose-incidence relationships for marrow failure in different species, in terms of radiosensitivity of tissue-rescuing units

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The development of lymphopenia in uremic patients undergoing extracorporeal irradiation of the blood with portable beta units

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Qualitative and quantitative reactions of lymphocytes to x rays

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphopenia produced by polyethylene-32P strips applied to the rabbit appendix

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic and local immunosuppression in pancreatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute-phase protein response and survival duration of patients with pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23648440

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/COC.0B013E3182940FF9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23648440%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37710295&oldid=1541218629"